Literature DB >> 7977460

De novo proximal interstitial deletions of 14q: cytogenetic and molecular investigations.

S K Shapira1, K L Anderson, A Orr-Urtregar, W J Craigen, J R Lupski, L G Shaffer.   

Abstract

We report on 2 unrelated patients who had chromosome analysis performed because of psychomotor delay, failure to thrive, and minor anomalies. Each patient had a novel proximal 14q deletion (q11.2 to q21.1 in patient 737 and q12 to q22 in patient 777). Polymorphic (C-A)n microsatellite markers distributed along the length of chromosome 14q were examined in both patients and their parents in order to determine which marker loci were deleted. The deletion in patient 737 was found to be paternal in origin, based on the analysis of 2 marker loci (D14S54 and D14S70), thus assigning these loci to the deleted interval q11.2 q21.1. Furthermore, 3 loci were not deleted (TCRD, D14S50, and D14S80), suggesting that they are within or proximal to 14q11.2. In the other family (patient 777), none of the markers were fully informative, but the deleted chromosome was determined to be paternally derived based on cytogenetic heteromorphisms. Despite having overlapping proximal 14q deletions, these 2 patients shared few phenotypic similarities except for failure to thrive, micrognathia, and hypoplasia of the corpus callosum. Therefore, a distinct proximal 14q deletion syndrome is not yet apparent. However, the molecular analyses facilitated the localization of several 14q DNA markers to the deletion regions in these 2 patients, while excluding other markers from each deletion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7977460     DOI: 10.1002/ajmg.1320520109

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  8 in total

Review 1.  Prenatal diagnosis of de novo proximal interstitial deletion of 14q associated with cebocephaly.

Authors:  C P Chen; C C Lee; L F Chen; C Y Chuang; S W Jan; B F Chen
Journal:  J Med Genet       Date:  1997-09       Impact factor: 6.318

2.  Parental and chromosomal origin of unbalanced de novo structural chromosome abnormalities in man.

Authors:  N Simon Thomas; Miranda Durkie; Berendine Van Zyl; Richard Sanford; Gemma Potts; Sheila Youings; Nicholas Dennis; Patricia Jacobs
Journal:  Hum Genet       Date:  2006-02-22       Impact factor: 4.132

3.  De novo unbalanced translocation resulting in monosomy for proximal 14q and distal 4p in a fetus with intrauterine growth retardation, Wolf-Hirschhorn syndrome, hypertrophic cardiomyopathy, and partial hemihypoplasia.

Authors:  C P Chen; S R Chern; C C Lee; W L Chen; M H Chen; K M Chang
Journal:  J Med Genet       Date:  1998-12       Impact factor: 6.318

4.  Unbalanced X; autosome translocation.

Authors:  Neerja Gupta; Himanshu Goel; Shubha R Phadke
Journal:  Indian J Pediatr       Date:  2006-09       Impact factor: 1.967

5.  Novel deletions of 14q11.2 associated with developmental delay, cognitive impairment and similar minor anomalies in three children.

Authors:  Farah Zahir; Helen V Firth; Agnes Baross; Allen D Delaney; Patrice Eydoux; William T Gibson; Sylvie Langlois; Howard Martin; Lionel Willatt; Marco A Marra; Jan M Friedman
Journal:  J Med Genet       Date:  2007-06-01       Impact factor: 6.318

6.  Msx1 haploinsufficiency modifies the Pax9-deficient cardiovascular phenotype.

Authors:  Ramada R Khasawneh; Ralf Kist; Rachel Queen; Rafiqul Hussain; Jonathan Coxhead; Jürgen E Schneider; Timothy J Mohun; Stéphane Zaffran; Heiko Peters; Helen M Phillips; Simon D Bamforth
Journal:  BMC Dev Biol       Date:  2021-10-06       Impact factor: 1.978

Review 7.  PAX Genes in Cardiovascular Development.

Authors:  Rebecca E Steele; Rachel Sanders; Helen M Phillips; Simon D Bamforth
Journal:  Int J Mol Sci       Date:  2022-07-12       Impact factor: 6.208

Review 8.  14q12q13.2 microdeletion syndrome: Clinical characterization of a new patient, review of the literature, and further evidence of a candidate region for CNS anomalies.

Authors:  Emanuela Ponzi; Mattia Gentile; Emanuele Agolini; Emilia Matera; Roberto Palumbi; Antonia Lucia Buonadonna; Antonia Peschechera; Alessandra Gabellone; Maria Fatima Antonucci; Lucia Margari
Journal:  Mol Genet Genomic Med       Date:  2020-05-16       Impact factor: 2.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.